Boston Scientific Completes Acquisition of Rubicon Medical Corporation NATICK, Mass., June 15 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced that it has completed the final phase of its acquisition of Rubicon Medical Corporation (OTC:RMDC) (BULLETIN BOARD: RMDC) . Boston Scientific previously completed a cash tender offer for any and all outstanding common stock of Rubicon on June 1, 2005. The tender offer was followed by the merger of Nemo I Acquisition, Inc., a wholly-owned subsidiary of Boston Scientific, with and into Rubicon on June 14, 2005. Following the merger, Rubicon became a wholly-owned subsidiary of Boston Scientific. About Boston Scientific Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com/. About Rubicon Medical Rubicon Medical Corporation (http://www.rubiconmed.com/) is a Salt Lake City-based developer and manufacturer of interventional vascular medical devices and products. CONTACT: Milan Kofol 508-650-8569 Investor Relations Boston Scientific Corporation Paul Donovan 508-650-8541 Media Relations Boston Scientific Corporation DATASOURCE: Boston Scientific Corporation CONTACT: Milan Kofol, Investor Relations, +1-508-650-8569, or Paul Donovan, Media Relations, +1-508-650-8541, both of Boston Scientific Corporation Web site: http://www.bostonscientific.com/ http://www.rubiconmed.com/

Copyright